Skip to main content
Premium Trial:

Request an Annual Quote

Leica, RareCyte to Co-Market CTC Technologies

NEW YORK (GenomeWeb) – Danaher's Leica Biosystems and RareCyte recently announced a co-marketing agreement covering Leica's Bond RX research staining platform and RareCyte's AccuCyte CyteFinder rare cell analysis product. 

According to the companies, the deal will provide researchers a fully automated solution for immunostaining captured circulating tumor cells deposited on microscope slides. The Bond RX platform is an open and flexible system that provides a high-throughput workflow. RareCyte's AccuCyte CyteFinder is an automated image analysis platform that enables the analysis of cells in up to six immunofluorescence channels. The combination of the technologies will accelerate the development of clinical applications for CTCs, the partners said. 

"This will enable us to provide an integrated platform that combines rare cell identification and single-cell analysis capability," RareCyte CEO Ron Seubert said in a statement, adding the deal will make CTC analysis widely available to the scientific and diagnostics research community. 

Financial and other terms of the deal were not disclosed. 

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.